Business Description
Britannia Life Sciences Inc
NAICS : 541710
SIC : 3741
ISIN : CA11042D1087
Description
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 74.83 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.02 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5 | |||||
Beneish M-Score | 0.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -57.5 | |||||
3-Year EBITDA Growth Rate | 25 | |||||
3-Year Book Growth Rate | 43.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.36 | |||||
9-Day RSI | 58.85 | |||||
14-Day RSI | 54.31 | |||||
3-1 Month Momentum % | -38.55 | |||||
6-1 Month Momentum % | -42.05 | |||||
12-1 Month Momentum % | -12.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.57 | |||||
Quick Ratio | 6.57 | |||||
Cash Ratio | 5.99 | |||||
Days Inventory | 189.84 | |||||
Days Sales Outstanding | 372.99 | |||||
Days Payable | 2620.37 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.47 | |||||
Operating Margin % | -298.74 | |||||
Net Margin % | 3084.42 | |||||
EBITDA Margin % | 2878.11 | |||||
FCF Margin % | -251.54 | |||||
OCF Margin % | -251.54 | |||||
ROE % | 133.48 | |||||
ROA % | 94.32 | |||||
ROIC % | -31.35 | |||||
3-Year ROIIC % | 14.86 | |||||
ROC (Joel Greenblatt) % | 12214.54 | |||||
ROCE % | 112.07 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 0.64 | |||||
PE Ratio without NRI | 5.83 | |||||
Price-to-Owner-Earnings | 0.93 | |||||
PS Ratio | 35 | |||||
PB Ratio | 0.55 | |||||
Price-to-Tangible-Book | 0.57 | |||||
EV-to-EBIT | -0.4 | |||||
EV-to-EBITDA | -0.39 | |||||
EV-to-Revenue | -11.34 | |||||
EV-to-FCF | 4.66 | |||||
Price-to-Graham-Number | 0.36 | |||||
| Price-to-Net-Current-Asset-Value | 0.71 | |||||
| Price-to-Net-Cash | 0.71 | |||||
Earnings Yield (Greenblatt) % | -250 | |||||
FCF Yield % | -10.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Britannia Life Sciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.293 | ||
| EPS (TTM) (€) | 0.069 | ||
| Beta | -0.3234 | ||
| 3-Year Sharpe Ratio | 0.31 | ||
| 3-Year Sortino Ratio | 0.65 | ||
| Volatility % | 65.53 | ||
| 14-Day RSI | 54.31 | ||
| 14-Day ATR (€) | 0.000881 | ||
| 20-Day SMA (€) | 0.026925 | ||
| 12-1 Month Momentum % | -12.07 | ||
| 52-Week Range (€) | 0.025 - 0.071 | ||
| Shares Outstanding (Mil) | 164.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Britannia Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Britannia Life Sciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Britannia Life Sciences Inc Frequently Asked Questions
What is Britannia Life Sciences Inc(FRA:L020)'s stock price today?
The current price of FRA:L020 is €0.03. The 52 week high of FRA:L020 is €0.07 and 52 week low is €0.03.
When is next earnings date of Britannia Life Sciences Inc(FRA:L020)?
The next earnings date of Britannia Life Sciences Inc(FRA:L020) is .
Does Britannia Life Sciences Inc(FRA:L020) pay dividends? If so, how much?
Britannia Life Sciences Inc(FRA:L020) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| The Power Play by The Market Herald Releases Interviews With Britannia Life Sciences, Vejii Holdings, and Eat Well Group | 2022-03-09 |
Articles on Britannia Life Sciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers